Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Saturn Oil & Gas Inc. Reports Q1 2023 Results and Record Production: https://www.irw-press.at/prcom/images/messages/2023/70599/Saturn_170523_ENPRcom.004.png
Saturn Oil & Gas Inc. Reports Q1 2023 Results and Record Production

CALGARY, ALBERTA – May 16, 2023 - Saturn Oil & Gas Inc. (TSXV: SOIL)(FSE: SMKA)(OTCQX: OILSF)(“Saturn” or the “Company”) is pleased to report its financial and operating results for the three

Saturn Oil & Gas Inc. gibt Ergebnisse für 1. Quartal 2023 und Rekordproduktion bekannt: https://www.irw-press.at/prcom/images/messages/2023/70599/Saturn_170523_DEPRcom.004.png
Saturn Oil & Gas Inc. gibt Ergebnisse für 1. Quartal 2023 und Rekordproduktion bekannt

Calgary (Alberta), 16. Mai 2023 / IRW-Press / - Saturn Oil & Gas Inc. (TSX-V: SOIL) (FWB: SMKA) (OTCQX: OILSF) („Saturn“ oder das „Unternehmen“) freut sich, seine Finanz- und

Beam Global Shines Brightly in the EV Infrastructure Space: https://www.marketbeat.com/logos/articles/med_20230516104836_beam-global-shines-brightly-in-the-ev-infrastructu.jpg
Beam Global Shines Brightly in the EV Infrastructure Space

Beam Global Inc. (NASDAQ: BEEM) is emerging as a standout in the electric vehicle (EV) infrastructure space. As the EV movement continues to spread as more EVs get on the road, EV charging

The Turnaround for Weight Watchers is Taking Shape: https://www.marketbeat.com/logos/articles/med_20230514180546_charty-ww.jpg
The Turnaround for Weight Watchers is Taking Shape

Weight management meals and services provider WW International Inc. (NYSE: WW) stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares collapsed (26%) as Artal Group S.A

Sarepta Soars 31% As FDA Panel Backs Muscular Dystrophy Therapy: https://www.marketbeat.com/logos/articles/med_20230516050346_sarepta-soars-31-as-fda-panel-backs-muscular-dystr.jpg
Sarepta Soars 31% As FDA Panel Backs Muscular Dystrophy Therapy

Sarepta Therapeutics Inc. (NASDAQ: SRPT) jumped nearly 31% on May 15, after a Food and Drug Administration committee gave a thumbs up to the company’s experimental gene therapy to treat Duchenne

Is Novavax Finally Turning Things Around?: https://www.marketbeat.com/logos/articles/med_20230514175918_chartt-nvax.jpg
Is Novavax Finally Turning Things Around?

Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19, influenza

UnitedHealth Group is an AI Stock That Isn't Beating Expectations: https://www.marketbeat.com/logos/articles/med_20230515071148_unitedhealth-group-is-an-ai-stock-that-isnt-beatin.jpg
UnitedHealth Group is an AI Stock That Isn't Beating Expectations

UnitedHealth Group Inc. (NYSE: UNH) is down 7.2% in 2023. The health maintenance organization (HMO) sector in general is lagging the market. So, investors may simply be taking a pause on a stock

German International School of Silicon Valley wird für innovatives KI-Projekt mit hochdotiertem Preis der Deutschen Industrie- und Handelskammer (IHK) ausgezeichnet: https://www.irw-press.at/prcom/images/messages/2023/70502/GermanInternationalSchool_110523_DEPRcom.003.jpeg
German International School of Silicon Valley wird für innovatives KI-Projekt mit hochdotiertem Preis der Deutschen Industrie- und Handelskammer (IHK) ausgezeichnet

MOUNTAIN VIEW und SAN FRANCISCO, KALIFORNIEN / ACCESSWIRE / 11. Mai 2023 / Die German International School of Silicon Valley (GISSV) wurde im Rahmen des von der Deutschen Industrie- und

MicroVision meldet Ergebnisse für das erste Quartal 2023: https://www.irw-press.at/prcom/images/messages/2023/70464/MICROVISION-PR-050923_DEPRcom.003.png
MicroVision meldet Ergebnisse für das erste Quartal 2023

 

Redmond, WA/ACCESSWIRE/9. Mai 2023/ MicroVision, Inc. (NASDAQ:MVIS), ein führender Anbieter von MEMS-basierten Festkörper-Automobil-LiDAR- und modernen Fahrerassistenzsystemen (ADAS), gab

MicroVision Announces First Quarter 2023 Results: https://www.irw-press.at/prcom/images/messages/2023/70464/MICROVISION-PR-050923_PRcom.003.png
MicroVision Announces First Quarter 2023 Results

REDMOND, WA / ACCESSWIRE / May 9, 2023 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its first quarter 2023

ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results: https://www.marketbeat.com/logos/articles/med_20230507142135_chartt-imgn.jpg
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results

Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug Elahere shows statistical improvements for

Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales: https://www.marketbeat.com/logos/articles/med_20230504211613_regeneron-beats-q1-views-but-stock-drops-on-weak-e.jpg
Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) gapped down more than 6% on May 4, despite reporting better-than-expected first-quarter earnings and revenue.

Net income tumbled by 12% to $10.09 a

Will Forced Divesture Of Grail Boost Illumina Shareholder Value?: https://www.marketbeat.com/logos/articles/med_20230502151412_will-forced-divesture-of-grail-boost-illumina-shar.jpg
Will Forced Divesture Of Grail Boost Illumina Shareholder Value?

The phrase, “I’m from the government and I’m here to help” has a well-deserved reputation as a terrifying phrase, but for medical researcher Illumina Inc. (NASDAQ: ILMN), which specializes in DNA

Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding: https://www.marketbeat.com/logos/articles/med_20230502115431_chart-canf.jpg
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding

Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction. It

High-Yield Pfizer Falls Off The COVID Cliff, And Survives: https://www.marketbeat.com/logos/articles/med_20230502093017_chart-pfe-522023.png
High-Yield Pfizer Falls Off The COVID Cliff, And Survives

Pfizer (NYSE: PFE) was expected to post a significant decline in revenue and earnings because of the slowing COVID business, and it did. However, the takeaway from the report is that business is

Can Butterfly Network Spread its Wings in 2023?: https://www.marketbeat.com/logos/articles/med_20230430132321_chart-blfy.jpg
Can Butterfly Network Spread its Wings in 2023?

Butterfly Network Inc. (NYSE: BFLY) is a medical imaging solutions company that makes point-of-demand portable ultrasound devices to bring medical imaging to healthcare providers at a deep

Neptune Digital Assets meldet einen Gesamtnettogewinn von $2,7 Millionen im 2. Quartal: https://www.irw-press.at/prcom/images/messages/2023/70333/NDAQ22023_de_PRcom.001.png
Neptune Digital Assets meldet einen Gesamtnettogewinn von $2,7 Millionen im 2. Quartal

Vancouver, British Columbia – 2. Mai 2023 / IRW-Press / – Neptune Digital Assets Corp. (TSX-V:NDA) (OTCQB:NPPTF) (FWB:1NW) („Neptune“ oder das „Unternehmen“), eines der ersten börsennotierten

Neptune Digital Assets Announces Comprehensive Net Income of $2.7 Million in Q2: https://www.irw-press.at/prcom/images/messages/2023/70333/NDAQ22023_en_PRcom.001.png
Neptune Digital Assets Announces Comprehensive Net Income of $2.7 Million in Q2

VANCOUVER, British Columbia – May 2, 2023 – Neptune Digital Assets Corp. (TSX-V:NDA) (OTCQB:NPPTF) (FSE:1NW) (“Neptune” or the "Company"), one of the first publicly traded blockchain

Joby Aviation Extends Deal With Air Force, Analysts Maintain Hold: https://www.marketbeat.com/logos/articles/med_20230427111458_joby-aviations-55m-air-force-contract-extension.png
Joby Aviation Extends Deal With Air Force, Analysts Maintain Hold

Joby Aviation (NYSE: JOBY), a leader in the electric vertical takeoff and landing (eVTOL) aircraft industry, recently received a $55 million contract extension from the US Air Force for up to nine

Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal: https://www.marketbeat.com/logos/articles/med_20230425102047_chart-viri.jpg
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal

Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia and other abnormal immune

Why Legend Biotech Stock Is Having Its Best Month Yet: https://www.marketbeat.com/logos/articles/med_20230424135734_why-legend-biotech-stock-is-having-its-best-month.jpg
Why Legend Biotech Stock Is Having Its Best Month Yet

Legend Biotech Corporation (NASDAQ: LEGN) is among the many healthcare names vying for a breakthrough in cancer treatment. Last week, the New Jersey-based company had just that.

On April 19th, a

Medtronic: Reversal In-Play For This High-Yield Stock: https://www.marketbeat.com/logos/articles/med_20230424105754_chart-mdt-4242023.png
Medtronic: Reversal In-Play For This High-Yield Stock

The med-tech companies have gotten a lot of attention lately, and Medtronic (NYSE: MDT) is included. The rebound in procedures and healthcare services following the pandemic drives a rebound in

Are Rising Interest Rates Killing AT&T Stock?: https://www.marketbeat.com/logos/articles/med_20230423182531_charty-t.jpg
Are Rising Interest Rates Killing AT&T Stock?

Telecom giant AT&T Inc. (NYSE: T) spun off its Warnermedia division to merge with Discovery Networks to form Warner Bros. Discovery Inc. (NYSE: WBD) to reduce some of its massive debt load. AT&T

Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher: https://www.marketbeat.com/logos/articles/med_20230412102502_shockwave-medical-gets-10-jolt-leads-medical-gear.jpg
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher

The old saying, “I’m from the government, I’m here to help,” is always intended as a punchline, but a Medicare rule changes sure did help shares of Shockwave Medical Inc. (NASDAQ: SWAV)

Shares

Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher: https://www.marketbeat.com/logos/articles/med_20230411111847_chart-tlry-4112023.png
Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher

 

Tilray Brands (NASDAQ: TLRY) reported a mixed quarter and a deal to acquire HEXO that sent the market moving lower. While the news is less than spectacular, there are some takeaways for